학술논문
Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
Document Type
Article
Author
Source
In: European Journal of Health Economics . (European Journal of Health Economics, 1 March 2020, 21(2):219-233)
Subject
Language
English
ISSN
16187601
16187598
16187598